Your browser doesn't support javascript.
loading
Eosinophilic lymph node abscesses following a COVID-19 vaccination: A case report.
Kaya, Abdurrahman; Kaya, Sibel Yildiz; Abul, Azat; Fener, Neslihan; Can, Ali; Mert, Ali.
Afiliação
  • Kaya A; Department of Infectious Diseases, Istanbul Training and Research Hospital. Electronic address: dr.abdkaya@hotmail.com.
  • Kaya SY; Department of Infectious Diseases, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa.
  • Abul A; Department of Infectious Diseases, Istanbul Training and Research Hospital.
  • Fener N; Department of pathology, Yedikule chest diseases and thoracic surgery training and research hospital.
  • Can A; Department of Internal Medicine, Division of Immunology and Allergic disease, Van Training and Research Hospital.
  • Mert A; Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medipol University.
J Natl Med Assoc ; 115(2): 144-146, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36681552
ABSTRACT
In this paper, we reported a 37-year-old man who developed several lymphadenopathies after using the second dose of Pfizer-BioNtech vaccination against SARS-CoV-2. The excisional lymph node biopsy showed eosinophil-rich inflammation with micro-abscesses. Although eosinophilic dermatosis and eosinophilic myocarditis have been described previously following COVID-19 vaccinations, eosinophilic lymph node abscess was not reported in the literature. In our case, all lesions were completely recovered with steroid treatment. The patient has been doing well and no recurrence has been observed for six months.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfadenopatia / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfadenopatia / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article